Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
14 studies found for:    "smith-lemli-opitz syndrome"
Show Display Options
Rank Status Study
1 Unknown  Phase II Study of Dietary Cholesterol for Smith-Lemli-Opitz Syndrome
Condition: Smith-Lemli-Opitz Syndrome
Intervention: Behavioral: diet
2 Completed
Has Results
Simvastatin Therapy in Smith-Lemli-Opitz Syndrome
Condition: Smith-Lemli-Opitz Syndrome
Interventions: Drug: Simvastatin Susp.;   Drug: OraPlus
3 Completed Treatment of the Cholesterol Defect in Smith-Lemli-Opitz Syndrome
Condition: Smith-Lemli-Opitz Syndrome
Intervention: Drug: crystalline cholesterol oil-based suspension
4 Completed
Has Results
Short-term Behavioral Effects of Cholesterol Therapy in Smith-Lemli-Opitz Syndrome
Condition: Smith-Lemli-Opitz Syndrome
Interventions: Dietary Supplement: Egg yolk preparation with cholesterol;   Dietary Supplement: Egg substitute, without cholesterol
5 Completed Estimation of the Carrier Frequency and Incidence of Smith-Lemli-Opitz Syndrome in African Americans
Condition: Smith-Lemli-Opitz Syndrome
Intervention:
6 Unknown  Sterol and Isoprenoid Disease Research Consortium: Smith-Lemli-Opitz Syndrome
Condition: Smith-Lemli-Opitz Syndrome
Intervention: Dietary Supplement: Cholesterol supplementation
7 Completed Prenatal Screening For Smith-Lemli-Opitz Syndrome
Conditions: Smith-Lemli-Opitz Syndrome;   Pregnancy
Intervention:
8 Unknown  SLOS: The Effect of Simvastatin in Patients Receiving Cholesterol Supplementation
Condition: Smith-Lemli-Opitz Syndrome
Interventions: Drug: Simvastatin;   Dietary Supplement: Lactose
9 Recruiting Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS)
Conditions: Smith-Lemli-Opitz Syndrome;   Cone-Rod Dystrophy;   Hearing Loss
Interventions: Drug: Antioxidants;   Drug: Cholesterol
10 Recruiting Study of Smith-Lemli-Opitz Syndrome
Conditions: Abnormalities;   Inborn Errors of Metabolism;   Mental Retardation;   Muscle Hypotonia;   Smith Lemli Opitz Syndrome
Intervention:
11 Withdrawn A Long-Term Study of Cholesterol Supplements for Smith-Lemli-Opitz Syndrome
Condition: Smith-Lemi-Opitz Syndrome
Intervention:
12 Withdrawn Novel Treatment for Syndromic Ichthyoses
Conditions: Syndromic Ichthyoses;   CHILD Syndrome;   Smith Lemli Opitz Syndrome;   Conradi Syndrome
Intervention: Drug: Lovastatin
13 Recruiting Study of Inborn Errors of Cholesterol Synthesis and Related Disorders
Condition: Lipoidosis
Intervention:
14 Completed Cholesterol in ASD: Characterization and Treatment
Conditions: Autism;   Asperger Disorder;   PDD-NOS
Intervention: Other: Cholesterol

Study has passed its completion date and status has not been verified in more than two years.